Vaccine maker Moderna forecasts decrease gross sales subsequent yr, shares tumble 17% to close four-year low
Moderna pushed again its break-even aim by two years on Thursday because it delayed the timeline for creating a number...
fouryear
Moderna pushed again its break-even aim by two years on Thursday because it delayed the timeline for creating a number...
